Knoll Capital Management as of Sept. 30, 2017
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 16 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abeona Therapeutics | 34.4 | $40M | 2.4M | 17.05 | |
| Biohaven Pharmaceutical Holding | 25.8 | $30M | 807k | 37.35 | |
| Corbus Pharmaceuticals Hldgs | 22.9 | $27M | 3.7M | 7.15 | |
| Vascular Biogenics | 4.5 | $5.2M | 861k | 6.10 | |
| Anavex Life Sciences (AVXL) | 2.6 | $3.0M | 724k | 4.14 | |
| Krystal Biotech (KRYS) | 2.6 | $3.0M | 300k | 9.97 | |
| Ampio Pharmaceuticals | 1.4 | $1.6M | 2.6M | 0.62 | |
| Keryx Biopharmaceuticals | 1.2 | $1.4M | 200k | 7.10 | |
| Volitionrx (VNRX) | 1.1 | $1.2M | 462k | 2.69 | |
| Summit Therapeutics Plc spons ads | 1.0 | $1.2M | 92k | 12.55 | |
| Aldeyra Therapeutics (ALDX) | 0.8 | $894k | 124k | 7.20 | |
| Alcobra | 0.7 | $812k | 804k | 1.01 | |
| Evoke Pharma | 0.6 | $752k | 225k | 3.34 | |
| Caladrius Biosciences Ord | 0.4 | $422k | 118k | 3.58 | |
| Advaxis | 0.2 | $191k | 113k | 1.70 | |
| Lipocine | 0.1 | $99k | 25k | 3.96 |
